Dr. Citrin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2520 Elisha Avenue
Zion, IL 60099Phone+1 847-748-0627
Summary
- Dr. Dennis Citrin is an oncologist in Chicago, IL He received his medical degree and PhD from University of Glasgow Faculty of Medicine and has been in practice 48 years. He has served on the faculty of several medical schools, and is currently on faculty of Rosalind Franklin School of Medicine. He specializes in breast cancer.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1976 - 1977
University of Glasgow Faculty of MedicineClass of 1969
Certifications & Licensure
IL State Medical License 1982 - 2026- IL State Medical License 2020 - 2026
CT State Medical License 2024 - 2025
MN State Medical License 2024 - 2025
WI State Medical License 1977 - 1981- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer Start of enrollment: 2017 May 01
Publications & Presentations
PubMed
- 126 citationsEMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast CancerDenise A. Yardley, Robert Weaver, Michelle E. Melisko, Mansoor N. Saleh, Francis P. Arena
Journal of Clinical Oncology. 2015-05-10 - 4 citationsProlonged Self-Resolving Neutropenia Following Asymptomatic COVID-19 InfectionShreya Desai, Javairia Quraishi, Dennis Citrin
Cureus. 2021-07-18 - 53 citationsBeliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies.Dennis L. Citrin, Diane L. Bloom, James F. Grutsch, Sara J. Mortensen, Christopher G. Lis
The Oncologist. 2012-05-01
Press Mentions
Who, When, Why: Navigating Complex Breast Cancer Screening GuidelinesFebruary 17th, 2022- Omicron Variant Makes Itself Known over Holiday Weekend • Systems Partner to Promote Health Care Careers • NorthShore Program Encourages Genetic ScreeningNovember 29th, 2021
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
